RSC Advances
Paper
2962, 2877, 1816, 1733, 1164, 1051, 1010, 418; HRMS (ESI) calcd (m, 2H), 1.86–1.66 (m, 2H), 1.59 (qd, J ¼ 12.0, 6.7 Hz, 2H); 13C
for C16H21O2 (M + 1)+: 245.1536, found: 245.1540.
NMR (125 MHz, CDCl3) d 219.0, 49.2, 38.2, 26.7, 20.9; IR (KBr,
2-(2-Oxo-4-phenylbutyl)cyclopentanone (3g). The title cmꢂ1): 3446, 2962, 2873, 1733, 1449, 1133, 1000, 599, 418;
compound was prepared as colorless oil in 72% yield according HRMS (ESI) calcd for C10H15O2 (M + 1)+: 167.1067, found:
to the general procedure as described above; 1H NMR (500 MHz, 167.1070.
CDCl3) d 7.28 (dd, J ¼ 10.3, 4.6 Hz, 2H), 7.26–7.13 (m, 3H), 2.90
2-(2-Oxocyclopentyl)cycloheptanone (3l). The title compound
(t, J ¼ 7.7 Hz, 3H), 2.75 (dd, J ¼ 16.0, 8.1 Hz, 2H), 2.55–2.40 (m, was prepared as a white mixture of two diastereomers in 71%
2H), 2.40–2.30 (m, 1H), 2.27–2.13 (m, 2H), 2.10–2.00 (m, 1H), yield according to the general procedure as described above; 1H
1.89–1.74 (m, 1H), 1.49 (dd, J ¼ 11.9, 6.7 Hz, 1H); 13C NMR (125 NMR (400 MHz, CDCl3) d 3.09 (dt, J ¼ 7.6, 4.3 Hz, 1H), 2.92 (ddd, J
MHz, CDCl3) d 220.1, 207.9, 140.8, 128.5, 128.3, 126.1, 44.8, ¼ 12.9, 9.5, 6.5 Hz, 1H), 2.69–2.58 (m, 2H), 2.52 (ddd, J ¼ 16.2,
44.3, 42.5, 37.4, 29.7, 29.4, 20.7; HRMS (ESI) calcd for C15H19O2 6.5, 2.8 Hz, 1H), 2.47–2.30 (m, 3H), 2.30–2.23 (m, 1H), 2.23–2.09
(M + 1)+: 31.1380, found: 231.1381.
(m, 2H), 2.09–1.95 (m, 4H), 1.81 (qdd, J ¼ 25.2, 11.4, 6.2 Hz, 10H),
2-(4-Methyl-2-oxopentyl)cyclopentanone (3h).33 The title 1.71–1.47 (m, 6H), 1.47–1.17 (m, 3H); 13C NMR (100 MHz, CDCl3)
compound was prepared as colorless oil in 73% yield according d 220.0, 220.0, 214.5, 213.7, 52.4, 52.2, 51.7, 51.2, 43.9, 43.7, 37.9,
to the general procedure as described above; 1H NMR (500 MHz, 37.9, 30.1, 29.8, 29.7, 29.2, 29.1, 28.8, 26.3, 25.7, 23.9, 23.6, 21.0,
CDCl3) d 2.86 (d, J ¼ 16.6 Hz, 1H), 2.43 (ddd, J ¼ 61.0, 21.5, 8.9 20.7; IR (KBr, cmꢂ1): 3447, 2930, 2874, 1733, 1696, 1453, 1148,
Hz, 2H), 2.38–2.10 (m, 6H), 2.10–2.00 (m, 1H),1.81 (d, J ¼ 11.2 502, 418; HRMS (ESI) calcd for C12H19O2 (M + 1)+: 195.1380,
Hz, 1H), 1.53 (dd, J ¼ 11.5, 6.9 Hz, 1H), 0.92 (d, J ¼ 6.6 Hz, 6H); found: 195.1388.
13C NMR (125 MHz, CDCl3) d 220.2, 208.7, 51.8, 44.8, 42.9, 37.4,
2-(2-Oxo-2-phenylethyl)cyclohexanone (3m).36 The title
29.4, 24.7, 22.5, 22.5, 20.7; HRMS (ESI) calcd for C11H19O2 (M + compound was prepared as white solid in 62% yield according
1)+: 183.1385, found: 183.1386. to the general procedure as described above; 1H NMR (400 MHz,
2-(2-Oxotridecyl)cyclopentanone (3i). The title compound CDCl3) d 7.99 (dd, J ¼ 5.2, 3.3 Hz, 2H), 7.61–7.52 (m, 1H), 7.52–
was prepared as brown oil in 76% yield according to the general 7.41 (m, 2H), 3.61 (dd, J ¼ 17.7, 6.6 Hz, 1H), 3.17 (dd, J ¼ 12.7,
procedure as described above; 1H NMR (500 MHz, CDCl3) d 2.87 6.3 Hz, 1H), 2.69 (dd, J ¼ 17.7, 5.7 Hz, 1H), 2.49–2.39 (m, 2H),
(d, J ¼ 16.7 Hz, 1H), 2.57–2.13 (m, 7H), 2.12–1.98 (m, 1H), 1.98– 2.33–2.07 (m, 2H), 1.89 (dd, J ¼ 9.9, 6.4 Hz, 1H), 1.79 (dt, J ¼
1.70 (m, 1H), 1.61–1.39 (m, 3H), 1.25 (s, 16H), 0.88 (t, J ¼ 6.7 Hz, 12.7, 3.4 Hz, 1H), 1.73–1.64 (m, 1H), 1.46 (qd, J ¼ 12.8, 3.9 Hz,
3H); 13C NMR (125 MHz, CDCl3) d 220.3, 209.1, 44.8, 42.9, 42.3, 1H); 13C NMR (100 MHz, CDCl3) d 211.5, 198.6, 137.0, 133.0,
37.4, 31.9, 29.6, 29.5, 29.4, 29.3, 29.3, 29.1, 23.8, 22.6, 20.7, 14.1; 128.5, 128.0, 46.4, 41.9, 38.3, 34.3, 27.9, 25.3; HRMS (ESI) calcd
HRMS (ESI) calcd for C18H33O2 (M + 1)+: 281.2475, found: for C14H17O2 (M + 1)+: 217.1223, found: 217.1226.
281.2484.
2-(3-Oxopentan-2-yl)cyclohexanone
(3n).37
The
title
2-(2-Oxocyclopentyl)cyclohexanone (3j).34 Two diastereomers compound was prepared as brown oil in 39% yield according to
1
were prepared as white solid in 81% total yield according to the the general procedure as described above; H NMR (400 MHz,
general procedure as described above. The upper isomer: 1H CDCl3) d 2.90 (p, J ¼ 7.0 Hz, 1H), 2.65 (dd, J ¼ 13.0, 6.4 Hz, 1H),
NMR (400 MHz, CDCl3) d 2.85 (dd, J ¼ 7.7, 3.8 Hz, 1H), 2.60–2.47 2.61–2.54 (m, 1H), 2.48 (dt, J ¼ 10.8, 7.2 Hz, 1H), 2.42–2.25 (m,
(m, 1H), 2.42 (dd, J ¼ 14.0, 1.7 Hz, 1H), 2.39–2.25 (m, 2H), 2.25– 2H), 2.09–1.98 (m, 2H), 1.91–1.84 (m, 1H), 1.77–1.54 (m, 3H),
2.10 (m, 2H), 2.10–1.97 (m, 2H), 1.96–1.74 (m, 3H), 1.73–1.60 1.13 (d, J ¼ 7.1 Hz, 3H), 1.10–0.96 (m, 3H); 13C NMR (100 MHz,
(m, 4H); 13C NMR (100 MHz, CDCl3) d 220.7, 211.0, 50.5, 48.7, CDCl3) d 214.4, 211.7, 53.8, 44.8, 42.2, 35.4, 30.8, 27.7, 25.1, 14.8,
42.0, 38.4, 30.3, 27.4, 26.2, 25.3, 20.9; IR (KBr, cmꢂ1): 2938, 2863, 7.5; IR (KBr, cmꢂ1): 2938, 2864, 1759, 1708, 1450, 1281, 1167,
1734, 1706, 1465, 1316, 1141, 502, 463; HRMS (ESI) calcd for 1019, 974, 890; HRMS (ESI) calcd for C11H19O2 (M + 1)+:
C
11H17O2 (M + 1)+: 181.1223, found: 181.1226; the lower isomer: 183.1380, found: 183.1387.
1H NMR (400 MHz, CDCl3) d 3.09–2.94 (m, 1H), 2.54 (ddd, J ¼
2-(2-Oxo-1,3-diphenylpropyl)cyclohexanone (3o). The title
18.2, 11.9, 9.1 Hz, 1H), 2.45–2.21 (m, 3H), 2.16–1.95 (m, 5H), compound was prepared as brown oil in 51% yield according to
1
1.89 (dddd, J ¼ 18.0, 14.9, 7.4, 4.0 Hz, 2H), 1.79–1.52 (m, 4H); the general procedure as described above; H NMR (400 MHz,
13C NMR (100 MHz, CDCl3) d 220.3, 210.0, 51.2, 49.9, 41.9, 38.0, CDCl3) d 7.41–7.15 (m, 8H), 7.11–7.04 (m, 2H), 4.34 (d, J ¼ 7.3
31.8, 27.1, 25.4, 25.2, 21.2; IR (KBr, cmꢂ1): 3735, 2951, 2874, Hz, 1H), 3.71 (q, J ¼ 15.9 Hz, 2H), 2.96–2.71 (m, 1H), 2.38–2.19
1734, 1706, 1506, 1148, 418, 408; HRMS (ESI) calcd for C11H17O2 (m, 2H), 2.03–1.81 (m, 2H), 1.81–1.62 (m, 3H), 1.60–1.47 (m,
(M + 1)+: 181.1223, found: 181.1232.
1H); 13C NMR (100 MHz, CDCl3) d 211.1, 206.9, 136.6, 134.0,
[1,10-Bi(cyclopentane)]-2,20-dione (3k).35 Two diastereomers 129.7, 129.3, 128.7, 128.5, 127.3, 126.9, 56.3, 54.4, 49.6, 42.1,
were prepared as white solid in 80% total yield according to the 30.4, 27.5, 25.0; IR (KBr, cmꢂ1): 3059, 3028, 2924, 2852, 1768,
general procedure as described above. The upper isomer: 1H 1717, 1496, 1426, 1154, 1072, 736, 698, 521; HRMS (ESI) calcd
NMR (500 MHz, CDCl3) d 2.73–2.59 (m, 2H), 2.41–2.29 (m, 2H), for C21H23O2 (M + 1)+: 307.1693, found: 307.1695.
2.13–1.98 (m, 6H), 1.86–1.74 (m, 2H), 1.72–1.59 (m, 2H); 13C
5-Bromo-3-methyl-1-phenylhexane-1,4-dione (3p). The title
NMR (125 MHz, CDCl3) d 220.0, 48.5, 38.0, 25.3, 20.7; IR (KBr, compound was prepared as white solid in 32% yield according
cmꢂ1): 3447, 2963, 2878, 1734, 1405, 1145, 821, 488; HRMS (ESI) to the general procedure as described above; 1H NMR (400 MHz,
calcd for C10H15O2 (M + 1)+: 167.1067, found: 167.1071; the CDCl3) d 8.01–7.93 (m, 2H), 7.57 (dd, J ¼ 10.4, 4.3 Hz, 1H), 7.46
1
lower isomer: H NMR (500 MHz, CDCl3) d 2.60–2.48 (m, 2H), (t, J ¼ 7.6 Hz, 2H), 4.73 (q, J ¼ 6.8 Hz, 1H), 3.92–3.60 (m, 2H),
2.32 (ddd, J ¼ 18.6, 8.4, 1.1 Hz, 2H), 2.25–2.10 (m, 4H), 2.09–1.96 3.52 (dd, J ¼ 17.8, 7.0 Hz, 1H), 3.12 (dd, J ¼ 17.8, 5.8 Hz, 1H),
67906 | RSC Adv., 2015, 5, 67901–67908
This journal is © The Royal Society of Chemistry 2015